HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
Sys. Review
Pre-infection vaccination linked to lower cardiovascular and cerebrovascular event risks in SARS-CoV-2 infected individuals
Vaccination Before Infection Cuts Heart and Stroke Risks in COVID Patients
This systematic review and meta-analysis examined the association between pre-infection COVID-19 vaccination and cardiovascular outcomes in …
Pre-infection COVID-19 vaccination significantly lowers risks of heart attacks, strokes, and other cardiovascular events in infected individ…
medRxiv
May 23, 2026
Rheumatology
Meta-analysis
Meta-analysis finds modest PTS reduction with compression stockings after DVT
Long-term stockings lower risk of post-thrombotic syndrome in deep vein thrombosis patients
This meta-analysis of 1,775 patients with deep vein thrombosis evaluated long-term graduated compression stockings. It found a modest reduct…
A large review found long-term compression stockings modestly reduce the risk of post-thrombotic syndrome in people with deep vein thrombosi…
Frontiers
May 21, 2026
Oncology
Meta-analysis
Postoperative VTE prediction models show substantial heterogeneity and high bias risk in lung cancer surgery patients undergoing systematic review analysis
Existing lung cancer VTE prediction models show mixed results in surgery patients
A systematic review of twenty prediction models for venous thromboembolism in lung cancer surgery patients revealed substantial heterogeneit…
A review of twenty studies found that current tools for predicting blood clots in lung cancer surgery patients vary widely in accuracy and c…
Frontiers
May 20, 2026
Cardiology
Meta-analysis
Network meta-analysis compares DOACs and VKAs for intracranial hemorrhage risk
Dabigatran may be safest for brain bleeding risk
This network meta-analysis of 127,267 patients with venous thromboembolism or atrial fibrillation found that all DOACs had lower risk of int…
All blood thinners beat warfarin for brain bleed risk, but dabigatran may be the safest choice.
Frontiers
May 19, 2026
Radiology & Imaging
Meta-analysis
Systematic review and meta-analysis links D-dimer and ultrasound findings to recurrent venous thromboembolism risk
Doctors find high D-dimer levels and ultrasound results predict higher risk of blood clot return
This systematic review and meta-analysis of 48 articles evaluates the association between residual vein thrombosis and positive post-treatme…
A review of many studies shows that leftover blood clots and high D-dimer levels after treatment raise the chance of venous thromboembolism …
May 16, 2026
Drug Pipeline
Sys. Review
Systematic review of Dendrobium phenanthrene bioactivity across multiple disease models
Scientists found many plant chemicals that fight cancer and help diabetes in lab tests
This systematic review evaluates the bioactivity of 158 phenanthrene metabolites isolated from 53 Dendrobium taxa. The authors note that 64 …
A review of plant chemicals from Dendrobium plants shows strong activity against cancer and diabetes in lab studies. Most results come from …
Frontiers
May 15, 2026
Emergency Medicine
Meta-analysis
Subprophylactic anti-Xa levels linked to higher venous thromboembolism risk in critically ill adults receiving low-molecular-weight heparin
Low blood clot prevention drug levels linked to higher risk in sick adults
A systematic review and meta-analysis of 7,124 critically ill adults reveals that 47% failed to achieve target anti-Xa levels. Subprophylact…
A large review found that nearly half of critically ill adults did not reach safe drug levels. Those with lower levels faced a much higher c…
May 6, 2026
Ophthalmology
FDA Approval
FDA Approves Pavblu (aflibercept) for Neovascular AMD, RVO, DME, and DR
FDA approves Pavblu to treat several eye conditions that cause vision loss.
The FDA approved Pavblu (aflibercept) for neovascular AMD, macular edema following RVO, DME, and DR. It is a VEGF inhibitor administered by …
The FDA approved Pavblu (aflibercept) for wet age-related macular degeneration, macular edema, diabetic macular edema, and diabetic retinopa…
FDA
May 5, 2026
Hematology
Meta-analysis
Systematic review and meta-analysis finds high prevalence of ocular manifestations in leukemia patients
Leukemia patients face eye risks that doctors must spot early now
This systematic review and meta-analysis of 1016 patients with leukemia found a 42% prevalence of overall ocular manifestations.
New data shows almost half of leukemia patients have eye issues, so regular eye checks are essential for better care
May 1, 2026
Ophthalmology
Cohort
COVID-19 pandemic linked to no significant change in retinal vascular occlusion incidence at a Swiss eye hospital
COVID-19 Did Not Raise Eye Stroke Risk, Study Finds
This retrospective cohort study compared retinal vascular occlusion diagnoses in 2019 versus 2020 at a Swiss eye hospital.
New eye data shows COVID’s first year did not raise the risk of retinal vein or artery blockages.
Frontiers
Apr 27, 2026
Oncology
Meta-analysis
Meta-analysis identifies prognostic factors for recurrent VTE and bleeding in 96 753 adult cancer patients
Certain cancer types and health factors raise risk of blood clots or bleeding in adults with cancer and VTE
This meta-analysis evaluated prognostic factors for recurrent venous thromboembolism (VTE) or anticoagulant-related bleeding in 96 753 adult…
A large review found that specific cancers and health factors significantly increase the risk of recurrent blood clots or bleeding in adults…
Apr 23, 2026
Cardiology
Meta-analysis
Systematic review and meta-analysis finds high VTE incidence in stroke patients and moderate model performance
Doctors Rethink How to Spot Blood Clots in Stroke Patients
This systematic review and meta-analysis of seven prediction models found a pooled VTE incidence of 20.8% in stroke patients.
It starts with a small ache in the leg. A little swelling.
Frontiers
Apr 23, 2026